Drug
Betamethasone Dipropionate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Macular Degeneration | 532 | 151.8 | 165.3 | signal |
| 2 | Full Blood Count Abnormal | 129 | 40.2 | 41.0 | signal |
| 3 | Sleep Disorder Due To A General Medical Condition | 171 | 34.7 | 35.6 | signal |
| 4 | Obstructive Airways Disorder | 116 | 34.1 | 34.7 | signal |
| 5 | Arteriosclerosis | 94 | 32.7 | 33.2 | signal |
| 6 | Incorrect Route Of Product Administration | 160 | 31.2 | 32.0 | signal |
| 7 | Vasculitis | 110 | 30.9 | 31.4 | signal |
| 8 | Vaginal Discharge | 81 | 26.4 | 26.7 | signal |
| 9 | Drug Eruption | 142 | 26.4 | 26.9 | signal |
| 10 | Oral Candidiasis | 99 | 24.9 | 25.3 | signal |
| 11 | Paraesthesia Oral | 107 | 24.3 | 24.7 | signal |
| 12 | Appendicitis | 69 | 24.3 | 24.5 | signal |
| 13 | Pulmonary Fibrosis | 134 | 22.9 | 23.4 | signal |
| 14 | Nodule | 88 | 22.0 | 22.3 | signal |
| 15 | Hypercholesterolaemia | 63 | 21.5 | 21.7 | signal |
| 16 | Ventricular Fibrillation | 64 | 18.8 | 18.9 | signal |
| 17 | Skin Fissures | 100 | 17.3 | 17.5 | signal |
| 18 | Hyperlipidaemia | 58 | 15.8 | 15.9 | signal |
| 19 | Cardiogenic Shock | 65 | 14.9 | 15.0 | signal |
| 20 | Therapeutic Product Effect Incomplete | 320 | 14.8 | 15.5 | signal |
| 21 | Haemoptysis | 123 | 14.3 | 14.6 | signal |
| 22 | Psoriatic Arthropathy | 173 | 14.0 | 14.4 | signal |
| 23 | Frequent Bowel Movements | 115 | 13.9 | 14.2 | signal |
| 24 | Folliculitis | 44 | 13.9 | 14.0 | signal |
| 25 | Procedural Pain | 115 | 13.6 | 13.8 | signal |
| 26 | Bacterial Infection | 77 | 13.5 | 13.7 | signal |
| 27 | Hypothyroidism | 127 | 13.0 | 13.2 | signal |
| 28 | Hepatic Function Abnormal | 143 | 12.6 | 12.8 | signal |
| 29 | Psoriasis | 498 | 12.4 | 13.4 | signal |
| 30 | Lung Disorder | 182 | 12.1 | 12.4 | signal |
| 31 | Ulcer | 59 | 12.1 | 12.2 | signal |
| 32 | Aspiration | 39 | 11.7 | 11.8 | signal |
| 33 | Neuralgia | 84 | 11.3 | 11.4 | signal |
| 34 | Candida Infection | 56 | 10.9 | 11.0 | signal |
| 35 | End Stage Renal Disease | 60 | 10.6 | 10.7 | signal |
| 36 | Gout | 57 | 10.3 | 10.4 | signal |
| 37 | Multiple Organ Dysfunction Syndrome | 88 | 10.3 | 10.4 | signal |
| 38 | Hypoxia | 110 | 10.2 | 10.4 | signal |
| 39 | Dermatitis Atopic | 154 | 10.0 | 10.3 | signal |
| 40 | Joint Range Of Motion Decreased | 40 | 9.7 | 9.8 | signal |
| 41 | Back Injury | 32 | 9.6 | 9.7 | signal |
| 42 | Bursitis | 35 | 9.4 | 9.5 | signal |
| 43 | Metastases To Central Nervous System | 36 | 9.1 | 9.2 | signal |
| 44 | Eczema | 140 | 9.1 | 9.2 | signal |
| 45 | Blood Test Abnormal | 39 | 9.0 | 9.1 | signal |
| 46 | Brain Oedema | 35 | 9.0 | 9.1 | signal |
| 47 | Stomatitis | 166 | 8.9 | 9.1 | signal |
| 48 | Colitis | 103 | 8.9 | 9.0 | signal |
| 49 | Micturition Urgency | 31 | 8.9 | 8.9 | signal |
| 50 | Wheezing | 161 | 8.9 | 9.1 | signal |
| 51 | Autoimmune Disorder | 26 | 8.8 | 8.9 | signal |
| 52 | Helicobacter Infection | 27 | 8.6 | 8.7 | signal |
| 53 | Loss Of Personal Independence In Daily Activities | 123 | 8.4 | 8.6 | signal |
| 54 | Skin Lesion | 69 | 8.2 | 8.3 | signal |
| 55 | Colitis Ulcerative | 113 | 8.2 | 8.4 | signal |
| 56 | Red Blood Cell Sedimentation Rate Increased | 28 | 8.2 | 8.2 | signal |
| 57 | Poor Quality Sleep | 54 | 8.2 | 8.3 | signal |
| 58 | Rectal Haemorrhage | 106 | 8.0 | 8.1 | signal |
| 59 | Sleep Disorder | 172 | 8.0 | 8.2 | signal |
| 60 | Adrenal Insufficiency | 29 | 7.9 | 7.9 | signal |
| 61 | Ascites | 71 | 7.9 | 7.9 | signal |
| 62 | Skin Haemorrhage | 34 | 7.7 | 7.7 | signal |
| 63 | Middle Insomnia | 43 | 7.5 | 7.6 | signal |
| 64 | Wound | 64 | 7.5 | 7.6 | signal |
| 65 | C-reactive Protein Increased | 82 | 7.3 | 7.4 | signal |
| 66 | Irritable Bowel Syndrome | 48 | 7.3 | 7.4 | signal |
| 67 | Infusion Related Reaction | 148 | 7.3 | 7.4 | signal |
| 68 | Skin Exfoliation | 182 | 7.1 | 7.3 | signal |
| 69 | Pericarditis | 35 | 6.8 | 6.9 | signal |
| 70 | Productive Cough | 99 | 6.8 | 6.9 | signal |
| 71 | Obesity | 33 | 6.7 | 6.8 | signal |
| 72 | Joint Injury | 44 | 6.7 | 6.7 | signal |
| 73 | Thrombosis | 166 | 6.7 | 6.8 | signal |
| 74 | Dermatitis Contact | 23 | 6.6 | 6.6 | signal |
| 75 | Secretion Discharge | 25 | 6.6 | 6.6 | signal |
| 76 | Glossodynia | 45 | 6.5 | 6.6 | signal |
| 77 | Rib Fracture | 41 | 6.5 | 6.5 | signal |
| 78 | Taste Disorder | 40 | 6.5 | 6.5 | signal |
| 79 | Blood Cholesterol Increased | 93 | 6.5 | 6.6 | signal |
| 80 | Hand Deformity | 26 | 6.5 | 6.5 | signal |
| 81 | Asthma | 222 | 6.4 | 6.6 | signal |
| 82 | Haematochezia | 109 | 6.4 | 6.5 | signal |
| 83 | Synovitis | 34 | 6.1 | 6.2 | signal |
| 84 | Pulmonary Mass | 28 | 6.1 | 6.1 | signal |
| 85 | Body Temperature Increased | 37 | 5.9 | 5.9 | signal |
| 86 | Upper Respiratory Tract Infection | 83 | 5.8 | 5.9 | signal |
| 87 | Dyspepsia | 176 | 5.8 | 6.0 | signal |
| 88 | Pulmonary Embolism | 171 | 5.8 | 6.0 | signal |
| 89 | Epistaxis | 133 | 5.8 | 5.9 | signal |
| 90 | Application Site Pain | 39 | 5.8 | 5.8 | signal |
| 91 | Stress | 126 | 5.7 | 5.8 | signal |
| 92 | Hyponatraemia | 98 | 5.7 | 5.7 | signal |
| 93 | Erythema Multiforme | 16 | 5.6 | 5.6 | signal |
| 94 | Skin Infection | 19 | 5.5 | 5.5 | signal |
| 95 | Cellulitis | 84 | 5.4 | 5.5 | signal |
| 96 | Gait Inability | 55 | 5.4 | 5.4 | signal |
| 97 | Bacteraemia | 19 | 5.2 | 5.3 | signal |
| 98 | Chronic Obstructive Pulmonary Disease | 84 | 5.2 | 5.3 | signal |
| 99 | Muscle Twitching | 37 | 5.2 | 5.2 | signal |
| 100 | Liver Function Test Increased | 34 | 5.2 | 5.2 | signal |
| 101 | Skin Disorder | 53 | 5.2 | 5.2 | signal |
| 102 | Pain Of Skin | 43 | 5.2 | 5.2 | signal |
| 103 | Blister | 87 | 5.0 | 5.1 | signal |
| 104 | Scratch | 16 | 5.0 | 5.0 | signal |
| 105 | Lower Respiratory Tract Infection | 70 | 5.0 | 5.1 | signal |
| 106 | Transaminases Increased | 34 | 5.0 | 5.0 | signal |
| 107 | Contraindicated Product Administered | 46 | 5.0 | 5.0 | signal |
| 108 | Contusion | 144 | 4.9 | 5.0 | signal |
| 109 | Therapy Non-responder | 66 | 4.8 | 4.9 | signal |
| 110 | Coronary Artery Disease | 45 | 4.8 | 4.8 | signal |
| 111 | Wound Infection | 16 | 4.8 | 4.8 | signal |
| 112 | Diabetes Mellitus Inadequate Control | 26 | 4.8 | 4.8 | signal |
| 113 | Dermatitis | 30 | 4.7 | 4.7 | signal |
| 114 | Dry Mouth | 116 | 4.7 | 4.7 | signal |
| 115 | Impaired Healing | 47 | 4.7 | 4.7 | signal |
| 116 | Product Use In Unapproved Indication | 349 | 4.6 | 4.9 | signal |
| 117 | Inflammation | 73 | 4.6 | 4.7 | signal |
| 118 | Sedation | 37 | 4.6 | 4.6 | signal |
| 119 | Intervertebral Disc Degeneration | 13 | 4.5 | 4.5 | signal |
| 120 | Maternal Exposure During Pregnancy | 123 | 4.5 | 4.6 | signal |
| 121 | Condition Aggravated | 421 | 4.5 | 4.8 | signal |
| 122 | Sepsis | 155 | 4.5 | 4.6 | signal |
| 123 | Sciatica | 22 | 4.5 | 4.5 | signal |
| 124 | Movement Disorder | 44 | 4.4 | 4.5 | signal |
| 125 | Caesarean Section | 16 | 4.4 | 4.4 | signal |
| 126 | Pulmonary Congestion | 18 | 4.4 | 4.4 | signal |
| 127 | Pain In Extremity | 395 | 4.3 | 4.6 | signal |
| 128 | Hepatic Cirrhosis | 25 | 4.3 | 4.4 | signal |
| 129 | Night Sweats | 43 | 4.3 | 4.4 | signal |
| 130 | Scab | 15 | 4.3 | 4.3 | signal |
| 131 | Gastrooesophageal Reflux Disease | 106 | 4.3 | 4.4 | signal |
| 132 | Rash Pruritic | 71 | 4.3 | 4.3 | signal |
| 133 | Sensory Disturbance | 21 | 4.2 | 4.2 | signal |
| 134 | Swelling | 121 | 4.2 | 4.3 | signal |
| 135 | Feeling Hot | 79 | 4.2 | 4.2 | signal |
| 136 | Pemphigus | 16 | 4.2 | 4.2 | signal |
| 137 | Diabetes Mellitus | 97 | 4.1 | 4.2 | signal |
| 138 | Erythema | 260 | 4.1 | 4.2 | signal |
| 139 | Product Administered At Inappropriate Site | 23 | 4.1 | 4.1 | signal |
| 140 | Drug Intolerance | 121 | 4.1 | 4.1 | signal |
| 141 | Cardiovascular Disorder | 32 | 4.1 | 4.1 | signal |
| 142 | General Physical Health Deterioration | 143 | 4.0 | 4.1 | signal |
| 143 | Osteoporosis | 51 | 4.0 | 4.0 | signal |
| 144 | Incorrect Product Administration Duration | 25 | 4.0 | 4.0 | signal |
| 145 | Fungal Infection | 41 | 4.0 | 4.0 | signal |
| 146 | Pleural Effusion | 75 | 4.0 | 4.0 | signal |
| 147 | Product Prescribing Error | 29 | 4.0 | 4.0 | signal |
| 148 | Skin Reaction | 17 | 3.9 | 3.9 | signal |
| 149 | Pruritus | 456 | 3.9 | 4.1 | signal |
| 150 | Conjunctivitis | 22 | 3.9 | 3.9 | signal |
| 151 | Urticaria | 199 | 3.9 | 4.0 | signal |
| 152 | Oral Herpes | 23 | 3.8 | 3.9 | signal |
| 153 | Nightmare | 41 | 3.8 | 3.9 | signal |
| 154 | Liver Disorder | 52 | 3.8 | 3.8 | signal |
| 155 | Poor Quality Product Administered | 12 | 3.8 | 3.8 | signal |
| 156 | Sputum Discoloured | 11 | 3.8 | 3.8 | signal |
| 157 | Eye Infection | 13 | 3.8 | 3.8 | signal |
| 158 | Dry Skin | 152 | 3.8 | 3.8 | signal |
| 159 | Intentional Product Misuse | 100 | 3.7 | 3.8 | signal |
| 160 | Discomfort | 69 | 3.7 | 3.7 | signal |
| 161 | Drug Ineffective | 1,471 | 3.6 | 4.4 | signal |
| 162 | Gallbladder Disorder | 20 | 3.6 | 3.6 | signal |
| 163 | Hypersensitivity | 207 | 3.6 | 3.7 | signal |
| 164 | Osteoarthritis | 47 | 3.6 | 3.6 | signal |
| 165 | Arthritis | 86 | 3.5 | 3.6 | signal |
| 166 | Prescribed Overdose | 21 | 3.5 | 3.5 | signal |
| 167 | Musculoskeletal Stiffness | 95 | 3.5 | 3.6 | signal |
| 168 | Foot Deformity | 12 | 3.5 | 3.5 | signal |
| 169 | Peripheral Swelling | 165 | 3.5 | 3.6 | signal |
| 170 | Anaemia | 205 | 3.5 | 3.6 | signal |
| 171 | Oedema Peripheral | 130 | 3.5 | 3.5 | signal |
| 172 | Transient Ischaemic Attack | 36 | 3.5 | 3.5 | signal |
| 173 | Therapy Partial Responder | 16 | 3.5 | 3.5 | signal |
| 174 | Sars-cov-2 Test Positive | 14 | 3.4 | 3.4 | signal |
| 175 | Lower Limb Fracture | 20 | 3.4 | 3.4 | signal |
| 176 | Restlessness | 38 | 3.4 | 3.4 | signal |
| 177 | Muscle Spasms | 190 | 3.4 | 3.4 | signal |
| 178 | Oedema | 56 | 3.4 | 3.4 | signal |
| 179 | Fibromyalgia | 25 | 3.3 | 3.4 | signal |
| 180 | Vitamin D Deficiency | 10 | 3.3 | 3.3 | signal |
| 181 | Madarosis | 12 | 3.3 | 3.3 | signal |
| 182 | Hypertension | 217 | 3.3 | 3.4 | signal |
| 183 | Decreased Immune Responsiveness | 10 | 3.3 | 3.3 | signal |
| 184 | Laryngitis | 11 | 3.3 | 3.3 | signal |
| 185 | Constipation | 219 | 3.3 | 3.4 | signal |
| 186 | Blood Creatinine Increased | 66 | 3.3 | 3.3 | signal |
| 187 | Wrist Fracture | 12 | 3.3 | 3.3 | signal |
| 188 | Abdominal Distension | 103 | 3.2 | 3.3 | signal |
| 189 | Toxic Skin Eruption | 10 | 3.2 | 3.2 | signal |
| 190 | Burning Sensation | 69 | 3.2 | 3.2 | signal |
| 191 | Iron Deficiency Anaemia | 9 | 3.2 | 3.2 | signal |
| 192 | Ear Infection | 26 | 3.2 | 3.2 | signal |
| 193 | Weight Decreased | 272 | 3.2 | 3.3 | signal |
| 194 | Medication Error | 54 | 3.2 | 3.2 | signal |
| 195 | Skin Burning Sensation | 69 | 3.2 | 3.2 | signal |
| 196 | Abdominal Pain | 225 | 3.1 | 3.2 | signal |
| 197 | Basal Cell Carcinoma | 15 | 3.1 | 3.1 | signal |
| 198 | Migraine | 91 | 3.1 | 3.1 | signal |
| 199 | Road Traffic Accident | 40 | 3.1 | 3.1 | signal |
| 200 | Joint Swelling | 115 | 3.1 | 3.1 | signal |
| 201 | Inappropriate Schedule Of Product Administration | 168 | 3.1 | 3.1 | signal |
| 202 | Exposure During Pregnancy | 59 | 3.1 | 3.1 | signal |
| 203 | Type 2 Diabetes Mellitus | 32 | 3.1 | 3.1 | signal |
| 204 | Therapeutic Response Decreased | 57 | 3.1 | 3.1 | signal |
| 205 | Impaired Gastric Emptying | 12 | 3.1 | 3.1 | signal |
| 206 | Leukocytosis | 17 | 3.1 | 3.1 | signal |
| 207 | Skin Discolouration | 43 | 3.0 | 3.1 | signal |
| 208 | Blood Iron Decreased | 11 | 3.0 | 3.0 | signal |
| 209 | Drug Ineffective For Unapproved Indication | 52 | 3.0 | 3.0 | signal |
| 210 | Lymphadenopathy | 33 | 3.0 | 3.0 | signal |
| 211 | Musculoskeletal Discomfort | 16 | 3.0 | 3.0 | signal |
| 212 | Musculoskeletal Pain | 49 | 3.0 | 3.0 | signal |
| 213 | Rash | 401 | 3.0 | 3.1 | signal |
| 214 | Dysuria | 34 | 3.0 | 3.0 | signal |
| 215 | Body Temperature Decreased | 9 | 2.9 | 2.9 | signal |
| 216 | Ankle Fracture | 14 | 2.9 | 2.9 | signal |
| 217 | Vertigo | 55 | 2.9 | 2.9 | signal |
| 218 | Proteinuria | 17 | 2.9 | 2.9 | signal |
| 219 | Cardiomegaly | 11 | 2.9 | 2.9 | signal |
| 220 | Limb Injury | 24 | 2.9 | 2.9 | signal |
| 221 | Eye Pruritus | 29 | 2.9 | 2.9 | signal |
| 222 | Drug Prescribing Error | 17 | 2.8 | 2.8 | signal |
| 223 | Lacrimation Increased | 26 | 2.8 | 2.8 | signal |
| 224 | Presyncope | 21 | 2.8 | 2.8 | signal |
| 225 | Urosepsis | 8 | 2.8 | 2.8 | signal |
| 226 | Angina Pectoris | 25 | 2.8 | 2.8 | signal |
| 227 | Pneumonia | 280 | 2.8 | 2.9 | signal |
| 228 | Weight Fluctuation | 9 | 2.8 | 2.8 | signal |
| 229 | Pyrexia | 299 | 2.8 | 2.9 | signal |
| 230 | Anxiety | 246 | 2.8 | 2.9 | signal |
| 231 | Disability | 17 | 2.8 | 2.8 | signal |
| 232 | Eosinophilia | 15 | 2.8 | 2.8 | signal |
| 233 | Product Dose Omission In Error | 23 | 2.8 | 2.8 | signal |
| 234 | Hip Arthroplasty | 13 | 2.8 | 2.8 | signal |
| 235 | Joint Dislocation | 9 | 2.8 | 2.8 | signal |
| 236 | Rash Erythematous | 40 | 2.8 | 2.8 | signal |
| 237 | Hepatic Enzyme Increased | 58 | 2.8 | 2.8 | signal |
| 238 | Skin Ulcer | 22 | 2.8 | 2.8 | signal |
| 239 | Squamous Cell Carcinoma | 8 | 2.8 | 2.8 | signal |
| 240 | Leukaemia | 8 | 2.8 | 2.8 | signal |
| 241 | Dry Eye | 41 | 2.7 | 2.8 | signal |
| 242 | Muscle Rigidity | 10 | 2.7 | 2.7 | signal |
| 243 | Acute Respiratory Failure | 16 | 2.7 | 2.7 | signal |
| 244 | Impaired Quality Of Life | 12 | 2.7 | 2.7 | signal |
| 245 | Rash Macular | 29 | 2.7 | 2.7 | signal |
| 246 | Abdominal Discomfort | 139 | 2.7 | 2.7 | signal |
| 247 | Osteomyelitis | 15 | 2.7 | 2.7 | signal |
| 248 | Localised Infection | 20 | 2.7 | 2.7 | signal |
| 249 | Quality Of Life Decreased | 11 | 2.7 | 2.7 | signal |
| 250 | Depressed Mood | 43 | 2.7 | 2.7 | signal |
| 251 | Treatment Failure | 67 | 2.7 | 2.7 | signal |
| 252 | Scar | 14 | 2.7 | 2.7 | signal |
| 253 | Blood Pressure Decreased | 54 | 2.6 | 2.7 | signal |
| 254 | Inflammatory Bowel Disease | 8 | 2.6 | 2.6 | signal |
| 255 | Generalised Oedema | 10 | 2.6 | 2.6 | signal |
| 256 | Limb Discomfort | 25 | 2.6 | 2.6 | signal |
| 257 | Pharyngitis | 10 | 2.6 | 2.6 | signal |
| 258 | Toxic Epidermal Necrolysis | 12 | 2.6 | 2.6 | signal |
| 259 | Application Site Pruritus | 18 | 2.6 | 2.6 | signal |
| 260 | Faeces Discoloured | 17 | 2.5 | 2.6 | signal |
| 261 | Eye Discharge | 8 | 2.5 | 2.5 | signal |
| 262 | Pericardial Effusion | 18 | 2.5 | 2.5 | signal |
| 263 | Illness | 78 | 2.5 | 2.5 | signal |
| 264 | Aspartate Aminotransferase Increased | 41 | 2.5 | 2.5 | signal |
| 265 | Hiatus Hernia | 10 | 2.5 | 2.5 | signal |
| 266 | Ocular Hyperaemia | 36 | 2.5 | 2.5 | signal |
| 267 | Infection | 111 | 2.5 | 2.5 | signal |
| 268 | Palmar-plantar Erythrodysaesthesia Syndrome | 18 | 2.5 | 2.5 | signal |
| 269 | Gastrointestinal Disorder | 68 | 2.5 | 2.5 | signal |
| 270 | Mobility Decreased | 55 | 2.5 | 2.5 | signal |
| 271 | Blood Alkaline Phosphatase Increased | 19 | 2.5 | 2.5 | signal |
| 272 | Skin Irritation | 35 | 2.5 | 2.5 | signal |
| 273 | Increased Tendency To Bruise | 7 | 2.5 | 2.5 | signal |
| 274 | Cataract | 45 | 2.5 | 2.5 | signal |
| 275 | Memory Impairment | 104 | 2.5 | 2.5 | signal |
| 276 | Arthropathy | 42 | 2.4 | 2.5 | signal |
| 277 | Off Label Use | 649 | 2.4 | 2.6 | signal |
| 278 | Pain | 459 | 2.4 | 2.5 | signal |
| 279 | Therapeutic Product Effect Decreased | 33 | 2.4 | 2.4 | signal |
| 280 | Device Defective | 12 | 2.4 | 2.4 | signal |
| 281 | Panic Attack | 27 | 2.4 | 2.4 | signal |
| 282 | Intentional Product Use Issue | 65 | 2.4 | 2.4 | signal |
| 283 | Pharyngitis Streptococcal | 8 | 2.4 | 2.4 | signal |
| 284 | Eye Irritation | 41 | 2.4 | 2.4 | signal |
| 285 | Hypoaesthesia | 110 | 2.4 | 2.4 | signal |
| 286 | Neck Pain | 41 | 2.4 | 2.4 | signal |
| 287 | Ileus | 9 | 2.4 | 2.4 | signal |
| 288 | Product Use Issue | 136 | 2.4 | 2.4 | signal |
| 289 | Joint Stiffness | 19 | 2.4 | 2.4 | signal |
| 290 | Pneumonia Aspiration | 18 | 2.3 | 2.3 | signal |
| 291 | Mass | 10 | 2.3 | 2.3 | signal |
| 292 | Oral Pain | 16 | 2.3 | 2.3 | signal |
| 293 | Cognitive Disorder | 33 | 2.3 | 2.3 | signal |
| 294 | Seasonal Allergy | 10 | 2.3 | 2.3 | signal |
| 295 | Systemic Lupus Erythematosus | 25 | 2.3 | 2.3 | signal |
| 296 | Rebound Effect | 8 | 2.3 | 2.3 | signal |
| 297 | Drug Hypersensitivity | 136 | 2.3 | 2.3 | signal |
| 298 | Paralysis | 10 | 2.3 | 2.3 | signal |
| 299 | Herpes Zoster | 40 | 2.3 | 2.3 | signal |
| 300 | Neoplasm | 8 | 2.3 | 2.3 | signal |
| 301 | Sinusitis | 71 | 2.2 | 2.3 | signal |
| 302 | Ankylosing Spondylitis | 9 | 2.2 | 2.2 | signal |
| 303 | Nasopharyngitis | 127 | 2.2 | 2.3 | signal |
| 304 | Bronchitis | 51 | 2.2 | 2.2 | signal |
| 305 | Irritability | 41 | 2.2 | 2.2 | signal |
| 306 | Rash Maculo-papular | 15 | 2.2 | 2.2 | signal |
| 307 | Hyperhidrosis | 87 | 2.2 | 2.2 | signal |
| 308 | Glaucoma | 13 | 2.2 | 2.2 | signal |
| 309 | Tenderness | 7 | 2.2 | 2.2 | no signal |
| 310 | Colon Cancer | 10 | 2.2 | 2.2 | signal |
| 311 | Ear Pain | 13 | 2.2 | 2.2 | signal |
| 312 | Mouth Ulceration | 14 | 2.2 | 2.2 | signal |
| 313 | Blood Bilirubin Increased | 18 | 2.2 | 2.2 | signal |
| 314 | Staphylococcal Infection | 22 | 2.2 | 2.2 | signal |
| 315 | Nausea | 523 | 2.2 | 2.3 | signal |
| 316 | Liver Injury | 16 | 2.1 | 2.2 | signal |
| 317 | Hyperglycaemia | 24 | 2.1 | 2.2 | signal |
| 318 | Sinus Disorder | 13 | 2.1 | 2.1 | signal |
| 319 | Osteopenia | 10 | 2.1 | 2.1 | signal |
| 320 | Epilepsy | 20 | 2.1 | 2.1 | signal |
| 321 | Malaise | 287 | 2.1 | 2.2 | signal |
| 322 | Haematocrit Decreased | 13 | 2.1 | 2.1 | signal |
| 323 | Fluid Retention | 33 | 2.1 | 2.1 | signal |
| 324 | Hypercalcaemia | 8 | 2.1 | 2.1 | no signal |
| 325 | Cyst | 8 | 2.1 | 2.1 | no signal |
| 326 | Dysgeusia | 48 | 2.1 | 2.1 | signal |
| 327 | Osteonecrosis Of Jaw | 16 | 2.1 | 2.1 | signal |
| 328 | Hypoglycaemia | 31 | 2.1 | 2.1 | signal |
| 329 | Nasal Congestion | 37 | 2.1 | 2.1 | signal |
| 330 | Therapeutic Response Shortened | 20 | 2.0 | 2.0 | signal |
| 331 | Stevens-johnson Syndrome | 14 | 2.0 | 2.0 | signal |
| 332 | Supraventricular Tachycardia | 6 | 2.0 | 2.0 | no signal |
| 333 | Somnolence | 126 | 2.0 | 2.1 | signal |
| 334 | Pharyngeal Swelling | 6 | 2.0 | 2.0 | no signal |
| 335 | Pulmonary Oedema | 28 | 2.0 | 2.0 | signal |
| 336 | Heart Rate Decreased | 22 | 2.0 | 2.0 | signal |
| 337 | Renal Disorder | 29 | 2.0 | 2.0 | signal |
| 338 | Respiratory Tract Infection | 16 | 2.0 | 2.0 | signal |
| 339 | Back Pain | 143 | 2.0 | 2.0 | no signal |
| 340 | Platelet Count Increased | 8 | 2.0 | 2.0 | no signal |
| 341 | Product Dose Omission Issue | 174 | 2.0 | 2.0 | no signal |
| 342 | Arthralgia | 253 | 2.0 | 2.0 | no signal |
| 343 | Weight Increased | 136 | 2.0 | 2.0 | no signal |
| 344 | Alopecia | 120 | 2.0 | 2.0 | no signal |
| 345 | Bedridden | 8 | 2.0 | 2.0 | no signal |
| 346 | Dyspnoea | 344 | 2.0 | 2.0 | no signal |
| 347 | Immune System Disorder | 8 | 2.0 | 2.0 | no signal |
| 348 | Treatment Noncompliance | 33 | 2.0 | 2.0 | no signal |
| 349 | Headache | 380 | 2.0 | 2.0 | no signal |
| 350 | Prescribed Underdose | 12 | 2.0 | 2.0 | no signal |
| 351 | Upper Limb Fracture | 12 | 1.9 | 1.9 | no signal |
| 352 | Sexual Dysfunction | 7 | 1.9 | 1.9 | no signal |
| 353 | Spinal Pain | 7 | 1.9 | 1.9 | no signal |
| 354 | Withdrawal Syndrome | 25 | 1.9 | 1.9 | no signal |
| 355 | Sinus Congestion | 8 | 1.9 | 1.9 | no signal |
| 356 | Covid-19 Pneumonia | 7 | 1.9 | 1.9 | no signal |
| 357 | Vomiting | 276 | 1.9 | 2.0 | no signal |
| 358 | Diabetic Ketoacidosis | 14 | 1.9 | 1.9 | no signal |
| 359 | Drug-induced Liver Injury | 18 | 1.9 | 1.9 | no signal |
| 360 | Neuropathy Peripheral | 55 | 1.9 | 1.9 | no signal |
| 361 | Amnesia | 38 | 1.9 | 1.9 | no signal |
| 362 | Injection Site Discomfort | 6 | 1.9 | 1.9 | no signal |
| 363 | Nocturia | 7 | 1.9 | 1.9 | no signal |
| 364 | Product Odour Abnormal | 6 | 1.9 | 1.9 | no signal |
| 365 | Urinary Incontinence | 17 | 1.9 | 1.9 | no signal |
| 366 | Carpal Tunnel Syndrome | 8 | 1.9 | 1.9 | no signal |
| 367 | Eye Swelling | 21 | 1.8 | 1.8 | no signal |
| 368 | Chest Pain | 105 | 1.8 | 1.9 | no signal |
| 369 | Premature Delivery | 9 | 1.8 | 1.8 | no signal |
| 370 | Thirst | 10 | 1.8 | 1.8 | no signal |
| 371 | Interstitial Lung Disease | 27 | 1.8 | 1.8 | no signal |
| 372 | Muscle Atrophy | 7 | 1.8 | 1.8 | no signal |
| 373 | Hair Colour Changes | 7 | 1.8 | 1.8 | no signal |
| 374 | Glycosylated Haemoglobin Increased | 14 | 1.8 | 1.8 | no signal |
| 375 | Gastroenteritis Viral | 10 | 1.8 | 1.8 | no signal |
| 376 | Abdominal Pain Lower | 14 | 1.8 | 1.8 | no signal |
| 377 | Spinal Fracture | 11 | 1.8 | 1.8 | no signal |
| 378 | Oropharyngeal Pain | 51 | 1.8 | 1.8 | no signal |
| 379 | Brain Fog | 8 | 1.8 | 1.8 | no signal |
| 380 | White Blood Cell Count Increased | 21 | 1.8 | 1.8 | no signal |
| 381 | Eye Pain | 30 | 1.8 | 1.8 | no signal |
| 382 | Immunodeficiency | 8 | 1.8 | 1.8 | no signal |
| 383 | Rhinorrhoea | 35 | 1.8 | 1.8 | no signal |
| 384 | Neutrophil Count Decreased | 22 | 1.8 | 1.8 | no signal |
| 385 | Osteonecrosis | 18 | 1.8 | 1.8 | no signal |
| 386 | Expired Product Administered | 18 | 1.8 | 1.8 | no signal |
| 387 | Gamma-glutamyltransferase Increased | 12 | 1.8 | 1.8 | no signal |
| 388 | Diarrhoea | 347 | 1.8 | 1.8 | no signal |
| 389 | Insurance Issue | 8 | 1.7 | 1.7 | no signal |
| 390 | Rash Papular | 12 | 1.7 | 1.7 | no signal |
| 391 | Dyspnoea Exertional | 20 | 1.7 | 1.7 | no signal |
| 392 | Application Site Erythema | 14 | 1.7 | 1.7 | no signal |
| 393 | Eye Inflammation | 5 | 1.7 | 1.7 | no signal |
| 394 | Premature Baby | 16 | 1.7 | 1.7 | no signal |
| 395 | Febrile Neutropenia | 35 | 1.7 | 1.7 | no signal |
| 396 | Mental Disorder | 23 | 1.7 | 1.7 | no signal |
| 397 | Emotional Distress | 64 | 1.7 | 1.7 | no signal |
| 398 | Depression | 120 | 1.7 | 1.7 | no signal |
| 399 | Red Blood Cell Count Decreased | 15 | 1.7 | 1.7 | no signal |
| 400 | Malignant Melanoma | 7 | 1.7 | 1.7 | no signal |
| 401 | Dizziness Postural | 5 | 1.7 | 1.7 | no signal |
| 402 | Syncope | 52 | 1.7 | 1.7 | no signal |
| 403 | Flushing | 53 | 1.7 | 1.7 | no signal |
| 404 | Fatigue | 403 | 1.7 | 1.7 | no signal |
| 405 | Eye Disorder | 17 | 1.7 | 1.7 | no signal |
| 406 | Device Related Infection | 8 | 1.7 | 1.7 | no signal |
| 407 | Tachypnoea | 7 | 1.7 | 1.7 | no signal |
| 408 | Splenomegaly | 6 | 1.7 | 1.7 | no signal |
| 409 | Intentional Dose Omission | 14 | 1.7 | 1.7 | no signal |
| 410 | Abdominal Pain Upper | 105 | 1.7 | 1.7 | no signal |
| 411 | Urinary Retention | 17 | 1.7 | 1.7 | no signal |
| 412 | Insomnia | 136 | 1.7 | 1.7 | no signal |
| 413 | Influenza | 57 | 1.7 | 1.7 | no signal |
| 414 | Coeliac Disease | 5 | 1.7 | 1.7 | no signal |
| 415 | Lymphocyte Count Decreased | 9 | 1.7 | 1.7 | no signal |
| 416 | Blood Triglycerides Increased | 9 | 1.6 | 1.6 | no signal |
| 417 | Tremor | 84 | 1.6 | 1.6 | no signal |
| 418 | Hot Flush | 38 | 1.6 | 1.6 | no signal |
| 419 | Ataxia | 6 | 1.6 | 1.6 | no signal |
| 420 | Bladder Disorder | 5 | 1.6 | 1.6 | no signal |
| 421 | Cardiac Failure | 40 | 1.6 | 1.6 | no signal |
| 422 | Hepatic Failure | 15 | 1.6 | 1.6 | no signal |
| 423 | Restless Legs Syndrome | 9 | 1.6 | 1.6 | no signal |
| 424 | Product Prescribing Issue | 10 | 1.6 | 1.6 | no signal |
| 425 | Bone Disorder | 9 | 1.6 | 1.6 | no signal |
| 426 | Tooth Abscess | 5 | 1.6 | 1.6 | no signal |
| 427 | Therapeutic Response Unexpected | 22 | 1.6 | 1.6 | no signal |
| 428 | Neutrophil Count Increased | 5 | 1.6 | 1.6 | no signal |
| 429 | Wrong Technique In Device Usage Process | 22 | 1.6 | 1.6 | no signal |
| 430 | Knee Arthroplasty | 10 | 1.6 | 1.6 | no signal |
| 431 | Gait Disturbance | 92 | 1.6 | 1.6 | no signal |
| 432 | Haematuria | 16 | 1.5 | 1.5 | no signal |
| 433 | Rotator Cuff Syndrome | 6 | 1.5 | 1.5 | no signal |
| 434 | Injection Site Induration | 6 | 1.5 | 1.5 | no signal |
| 435 | Kidney Infection | 9 | 1.5 | 1.5 | no signal |
| 436 | Head Discomfort | 8 | 1.5 | 1.5 | no signal |
| 437 | Cold Sweat | 8 | 1.5 | 1.5 | no signal |
| 438 | Injury | 32 | 1.5 | 1.5 | no signal |
| 439 | Paraesthesia | 71 | 1.5 | 1.5 | no signal |
| 440 | Acute Myeloid Leukaemia | 7 | 1.5 | 1.5 | no signal |
| 441 | Ischaemic Stroke | 8 | 1.5 | 1.5 | no signal |
| 442 | Covid-19 | 79 | 1.4 | 1.5 | no signal |
| 443 | Pregnancy | 9 | 1.4 | 1.4 | no signal |
| 444 | Respiratory Tract Congestion | 7 | 1.4 | 1.4 | no signal |
| 445 | Application Site Rash | 6 | 1.4 | 1.4 | no signal |
| 446 | Diverticulitis | 12 | 1.4 | 1.4 | no signal |
| 447 | Muscle Tightness | 7 | 1.4 | 1.4 | no signal |
| 448 | Product Packaging Issue | 4 | 1.4 | 1.4 | no signal |
| 449 | Aphonia | 6 | 1.4 | 1.4 | no signal |
| 450 | Nephropathy | 4 | 1.4 | 1.4 | no signal |
| 451 | Injection Site Pain | 127 | 1.4 | 1.4 | no signal |
| 452 | Hyperthyroidism | 6 | 1.3 | 1.3 | no signal |
| 453 | Myelodysplastic Syndrome | 6 | 1.3 | 1.3 | no signal |
| 454 | Face Oedema | 7 | 1.3 | 1.3 | no signal |
| 455 | Hypokinesia | 6 | 1.3 | 1.3 | no signal |
| 456 | Adverse Event | 38 | 1.3 | 1.3 | no signal |
| 457 | Myelosuppression | 14 | 1.3 | 1.3 | no signal |
| 458 | Ill-defined Disorder | 25 | 1.3 | 1.3 | no signal |
| 459 | Vitreous Floaters | 4 | 1.3 | 1.3 | no signal |
| 460 | Blood Creatine Phosphokinase Increased | 12 | 1.3 | 1.3 | no signal |
| 461 | Injection Site Reaction | 28 | 1.3 | 1.3 | no signal |
| 462 | Feeling Abnormal | 98 | 1.3 | 1.3 | no signal |
| 463 | Visual Impairment | 50 | 1.3 | 1.3 | no signal |
| 464 | Application Site Irritation | 5 | 1.3 | 1.3 | no signal |
| 465 | Pneumocystis Jirovecii Pneumonia | 4 | 1.3 | 1.3 | no signal |
| 466 | Ovarian Cyst | 4 | 1.3 | 1.3 | no signal |
| 467 | Myalgia | 67 | 1.3 | 1.3 | no signal |
| 468 | Economic Problem | 6 | 1.3 | 1.3 | no signal |
| 469 | Abscess | 6 | 1.2 | 1.2 | no signal |
| 470 | Increased Appetite | 7 | 1.2 | 1.2 | no signal |
| 471 | Injection Site Swelling | 28 | 1.2 | 1.2 | no signal |
| 472 | Cerebral Infarction | 9 | 1.2 | 1.2 | no signal |
| 473 | Acute Hepatic Failure | 5 | 1.2 | 1.2 | no signal |
| 474 | Cytokine Release Syndrome | 7 | 1.2 | 1.2 | no signal |
| 475 | Product Packaging Quantity Issue | 4 | 1.2 | 1.2 | no signal |
| 476 | Hernia | 7 | 1.2 | 1.2 | no signal |
| 477 | Rheumatoid Arthritis | 41 | 1.2 | 1.2 | no signal |
| 478 | Product Complaint | 9 | 1.2 | 1.2 | no signal |
| 479 | Lymphopenia | 5 | 1.2 | 1.2 | no signal |
| 480 | Drug Effect Less Than Expected | 5 | 1.2 | 1.2 | no signal |
| 481 | Impaired Driving Ability | 4 | 1.1 | 1.1 | no signal |
| 482 | Bronchospasm | 5 | 1.1 | 1.1 | no signal |
| 483 | Metastases To Lung | 4 | 1.1 | 1.1 | no signal |
| 484 | Anhedonia | 9 | 1.1 | 1.1 | no signal |
| 485 | Local Swelling | 6 | 1.1 | 1.1 | no signal |
| 486 | Injection Site Urticaria | 8 | 1.1 | 1.1 | no signal |
| 487 | Accidental Overdose | 12 | 1.1 | 1.1 | no signal |
| 488 | Surgery | 19 | 1.1 | 1.1 | no signal |
| 489 | Retinal Detachment | 3 | 1.1 | 1.1 | no signal |
| 490 | Nerve Compression | 3 | 1.1 | 1.1 | no signal |
| 491 | Skin Cancer | 7 | 1.1 | 1.1 | no signal |
| 492 | Delusion | 5 | 1.0 | 1.0 | no signal |
| 493 | Injection Site Discolouration | 4 | 1.0 | 1.0 | no signal |
| 494 | Injection Site Extravasation | 4 | 1.0 | 1.0 | no signal |
| 495 | Cardiac Disorder | 30 | 1.0 | 1.0 | no signal |
| 496 | Pruritus Generalised | 7 | 1.0 | 1.0 | no signal |
| 497 | Therapy Interrupted | 22 | 1.0 | 1.0 | no signal |
| 498 | Angioedema | 14 | 1.0 | 1.0 | no signal |
| 499 | Suicidal Ideation | 29 | 1.0 | 1.0 | no signal |
| 500 | Mood Swings | 10 | 1.0 | 1.0 | no signal |
| 501 | Intraocular Pressure Increased | 4 | 1.0 | 1.0 | no signal |
| 502 | Affect Lability | 3 | 1.0 | 1.0 | no signal |
| 503 | Injection Site Bruising | 24 | 1.0 | 1.0 | no signal |
| 504 | Product Quality Issue | 41 | 1.0 | 1.0 | no signal |
| 505 | Drug Level Increased | 5 | 1.0 | 1.0 | no signal |
| 506 | Adverse Reaction | 4 | 1.0 | 1.0 | no signal |
| 507 | Incorrect Dose Administered | 67 | 1.0 | 1.0 | no signal |
| 508 | Uveitis | 4 | 1.0 | 1.0 | no signal |
| 509 | Hospitalisation | 45 | 1.0 | 1.0 | no signal |
| 510 | Inappropriate Antidiuretic Hormone Secretion | 3 | 1.0 | 1.0 | no signal |
| 511 | Injection Site Warmth | 6 | 0.9 | 0.9 | no signal |
| 512 | Drug Toxicity | 4 | 0.9 | 0.9 | no signal |
| 513 | Abnormal Dreams | 8 | 0.9 | 0.9 | no signal |
| 514 | Drug Administered At Inappropriate Site | 3 | 0.9 | 0.9 | no signal |
| 515 | Breast Cancer Metastatic | 3 | 0.9 | 0.9 | no signal |
| 516 | Pulmonary Arterial Hypertension | 4 | 0.9 | 0.9 | no signal |
| 517 | Injection Site Nodule | 3 | 0.9 | 0.9 | no signal |
| 518 | Accidental Exposure To Product | 27 | 0.9 | 0.9 | no signal |
| 519 | Device Malfunction | 18 | 0.9 | 0.9 | no signal |
| 520 | Fistula | 3 | 0.9 | 0.9 | no signal |
| 521 | Exposure Via Skin Contact | 6 | 0.9 | 0.9 | no signal |
| 522 | Acne | 20 | 0.9 | 0.9 | no signal |
| 523 | Underdose | 19 | 0.8 | 0.8 | no signal |
| 524 | Gastric Haemorrhage | 3 | 0.8 | 0.8 | no signal |
| 525 | Device Issue | 22 | 0.8 | 0.8 | no signal |
| 526 | Cytopenia | 3 | 0.8 | 0.8 | no signal |
| 527 | Extra Dose Administered | 10 | 0.8 | 0.8 | no signal |
| 528 | Inappropriate Schedule Of Drug Administration | 18 | 0.8 | 0.8 | no signal |
| 529 | Lactic Acidosis | 8 | 0.8 | 0.8 | no signal |
| 530 | Activities Of Daily Living Impaired | 5 | 0.8 | 0.8 | no signal |
| 531 | Needle Issue | 7 | 0.8 | 0.8 | no signal |
| 532 | Tendon Rupture | 3 | 0.8 | 0.8 | no signal |
| 533 | Product Dose Omission | 16 | 0.8 | 0.8 | no signal |
| 534 | Peritonitis | 5 | 0.8 | 0.8 | no signal |
| 535 | Injection Site Haemorrhage | 19 | 0.8 | 0.8 | no signal |
| 536 | Malignant Neoplasm Progression | 24 | 0.8 | 0.8 | no signal |
| 537 | Anger | 8 | 0.8 | 0.8 | no signal |
| 538 | Foetal Exposure During Pregnancy | 19 | 0.8 | 0.8 | no signal |
| 539 | Tuberculosis | 3 | 0.8 | 0.8 | no signal |
| 540 | Plasma Cell Myeloma | 9 | 0.7 | 0.7 | no signal |
| 541 | Anorexia | 3 | 0.7 | 0.7 | no signal |
| 542 | Syringe Issue | 4 | 0.7 | 0.7 | no signal |
| 543 | Incorrect Product Storage | 3 | 0.7 | 0.7 | no signal |
| 544 | Hair Texture Abnormal | 3 | 0.7 | 0.7 | no signal |
| 545 | Myocardial Infarction | 39 | 0.7 | 0.7 | no signal |
| 546 | Pelvic Pain | 4 | 0.7 | 0.7 | no signal |
| 547 | Lung Neoplasm Malignant | 9 | 0.7 | 0.7 | no signal |
| 548 | Central Nervous System Lesion | 3 | 0.7 | 0.7 | no signal |
| 549 | Prostatic Specific Antigen Increased | 3 | 0.7 | 0.7 | no signal |
| 550 | Injection Site Pruritus | 14 | 0.7 | 0.7 | no signal |
| 551 | Product Storage Error | 18 | 0.7 | 0.7 | no signal |
| 552 | Drug Effective For Unapproved Indication | 6 | 0.7 | 0.7 | no signal |
| 553 | Drug Exposure During Pregnancy | 7 | 0.7 | 0.7 | no signal |
| 554 | Product Physical Issue | 4 | 0.7 | 0.7 | no signal |
| 555 | Neoplasm Progression | 7 | 0.6 | 0.6 | no signal |
| 556 | Injection Site Rash | 6 | 0.6 | 0.6 | no signal |
| 557 | Bone Loss | 3 | 0.6 | 0.6 | no signal |
| 558 | No Adverse Event | 35 | 0.6 | 0.6 | no signal |
| 559 | Drug Reaction With Eosinophilia And Systemic Symptoms | 5 | 0.6 | 0.6 | no signal |
| 560 | Drug Dispensing Error | 3 | 0.6 | 0.6 | no signal |
| 561 | Product Preparation Error | 4 | 0.6 | 0.6 | no signal |
| 562 | Drug Administration Error | 6 | 0.6 | 0.6 | no signal |
| 563 | Injection Site Erythema | 23 | 0.6 | 0.6 | no signal |
| 564 | Multiple Fractures | 3 | 0.6 | 0.6 | no signal |
| 565 | Abortion Spontaneous | 7 | 0.6 | 0.6 | no signal |
| 566 | Device Use Issue | 3 | 0.6 | 0.6 | no signal |
| 567 | Incorrect Route Of Drug Administration | 6 | 0.5 | 0.5 | no signal |
| 568 | Drug Effect Decreased | 9 | 0.5 | 0.5 | no signal |
| 569 | Drug Effect Incomplete | 6 | 0.5 | 0.5 | no signal |
| 570 | Injection Site Mass | 6 | 0.5 | 0.5 | no signal |
| 571 | Bone Density Decreased | 5 | 0.5 | 0.5 | no signal |
| 572 | Incorrect Dose Administered By Device | 4 | 0.5 | 0.5 | no signal |
| 573 | Suicide Attempt | 9 | 0.5 | 0.5 | no signal |
| 574 | Drug Dose Omission | 23 | 0.4 | 0.4 | no signal |
| 575 | Breast Cancer | 12 | 0.4 | 0.4 | no signal |
| 576 | Multiple Sclerosis | 6 | 0.4 | 0.4 | no signal |
| 577 | Hepatic Cancer | 3 | 0.4 | 0.4 | no signal |
| 578 | Multiple Sclerosis Relapse | 8 | 0.4 | 0.4 | no signal |
| 579 | Device Delivery System Issue | 3 | 0.4 | 0.4 | no signal |
| 580 | Pharmaceutical Product Complaint | 3 | 0.4 | 0.4 | no signal |
| 581 | Breast Cancer Female | 3 | 0.4 | 0.4 | no signal |
| 582 | Dependence | 6 | 0.4 | 0.3 | no signal |
| 583 | Incorrect Drug Administration Duration | 3 | 0.3 | 0.3 | no signal |
| 584 | Prostate Cancer | 8 | 0.3 | 0.3 | no signal |
| 585 | Drug Withdrawal Syndrome | 8 | 0.3 | 0.3 | no signal |
| 586 | Renal Cancer | 4 | 0.3 | 0.3 | no signal |
| 587 | Drug Dependence | 13 | 0.3 | 0.3 | no signal |
| 588 | Drug Dose Omission By Device | 6 | 0.3 | 0.3 | no signal |
| 589 | Device Leakage | 3 | 0.2 | 0.2 | no signal |
| 590 | Bladder Cancer | 3 | 0.2 | 0.2 | no signal |
| 591 | Device Difficult To Use | 3 | 0.1 | 0.1 | no signal |